BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study.

Front Med (Lausanne) · 2025 · PMC12411489 · PMID 40917862

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

28.50, p = 0.044) and hemoglobin levels showed a trend toward better improvement in the telitacicept group, though this did not reach statistical significance (Δ = 19.50 vs. 16.00, p = 0.095).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

8.75, p = 0.259), although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.